On April 27, The Pew Charitable Trusts submitted comments to the U.S. Food and Drug Administration on the National Medical Device Postmarket Surveillance Planning Board's report, Strengthening Patient Care: Building an Effective National Medical Device Surveillance System.
The Planning Board—composed of a broad range of medical device, industry, and regulatory experts, as well as representatives from the private sector and federal agencies—is working to build a robust tracking system that will ensure the safety and effectiveness of medical devices, such as artificial hips and cardiac stents.